Source link : https://www.newshealth.biz/health-news/tcl1a-protein-identified-as-predictor-of-blinatumomab-response-in-relapsed-b-all/
A study presented at the American Society of Hematology annual meeting identified TCL1A as a potential predictive biomarker for blinatumomab (Blincyto) response in relapsed pediatric B-cell acute lymphoblastic leukemia (B-ALL). In this exclusive MedPage Today video, Andrew Hughes, MD, PhD, of the Children’s Hospital of Philadelphia, offers a summary of the groundbreaking findings on TCL1A […]
Author : News Health
Publish date : 2025-01-06 18:30:12
Copyright for syndicated content belongs to the linked Source.